MDMA-Assisted Therapy for Severe PTSD
The Carlat Psychiatry Report, Volume 20, Number 2, February 2022
Michael Posternak, MD.
Dr. Posternak has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
MDMA is being repurposed as part of drug-assisted psychotherapy for PTSD, and this trial will help determine whether it gains FDA approval for that use.